(Q32118812)

English

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Topaly J

1

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Zeller WJ

2

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Fruehauf S

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

342-347

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of in vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukemia and the disruption of normal hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of the Fas apoptotic cell death pathway by Abl.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402041

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402041

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32118812&oldid=2175456899"